Загрузка...
Synchronous Presence of EGFR, ALK Driver Mutations Along With PD L1 Overexpression in a Resected Early Stage Non-Small Cell Lung Cancer: A Case Report and Review of Literature
Treatment of lung cancer has been revolutionized with development of drugs that target key driver mutations and immune checkpoints. Until recently, it was believed that these driver mutations are mutually exclusive. However, few reports have emerged citing the presence of both mutations either synch...
Сохранить в:
| Опубликовано в: : | World J Oncol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elmer Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942208/ https://ncbi.nlm.nih.gov/pubmed/29760833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1090e |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|